CIK 0001878313
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 33,333 shares at $1.50 ($50,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 20,000 shares at $1.50 ($30,000)
- 4 Open-market buy Director bought 66,666 shares at $1.50 ($99,999)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 33,333 shares at $1.50 ($50,000)
- 4 Open-market buy Director bought 25,000 shares at $1.50 ($37,500)
- 4/A Open-market buy Director bought 50,000 shares at $1.50 ($75,000)
Page 4 of 13 · 248 filings